instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the dosage of drug 'CYCLOPHOSPHAMIDE'? | Brentuximab vedotin in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone as frontline treatment for patients with CD30-positive B-cell lymphomas.
We conducted a phase I/II multicenter trial using 6 cycles of brentuximab vedotin (BV) in combination with rituximab, cyclophosphamide, doxorubicin, a... | 750 MILLIGRAM/SQ. METER, QD, CYCLE OF 21 DAYS | DrugDosageText | CC BY-NC | 32414850 | 19,809,418 | 2021-06-01 |
What was the dosage of drug 'DOXORUBICIN'? | Brentuximab vedotin in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone as frontline treatment for patients with CD30-positive B-cell lymphomas.
We conducted a phase I/II multicenter trial using 6 cycles of brentuximab vedotin (BV) in combination with rituximab, cyclophosphamide, doxorubicin, a... | 50 MILLIGRAM/SQ. METER, QD, CYCLE OF 21 DAYS | DrugDosageText | CC BY-NC | 32414850 | 19,809,418 | 2021-06-01 |
What was the dosage of drug 'PREDNISONE'? | Brentuximab vedotin in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone as frontline treatment for patients with CD30-positive B-cell lymphomas.
We conducted a phase I/II multicenter trial using 6 cycles of brentuximab vedotin (BV) in combination with rituximab, cyclophosphamide, doxorubicin, a... | ORAL OR EQUIVALENT IV DOSE IN A CYCLE OF 21 DAYS; 100MG OR EQUIVALENT DOSE DAILY | DrugDosageText | CC BY-NC | 32414850 | 19,809,418 | 2021-06-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Anesthetic management of a parturient with Shone's syndrome -a case report with review of literature.
Shone's syndrome is a rare complex congenital cardiac condition, characterized by a supra-valvular mitral ring, parachute deformity of the mitral valve, aortic stenosis, and coarctation of the aorta.
A 26-year-old p... | BISOPROLOL, DIAMORPHINE, FUROSEMIDE | DrugsGivenReaction | CC BY-NC | 32434290 | 20,992,015 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Exposure during pregnancy'. | Anesthetic management of a parturient with Shone's syndrome -a case report with review of literature.
Shone's syndrome is a rare complex congenital cardiac condition, characterized by a supra-valvular mitral ring, parachute deformity of the mitral valve, aortic stenosis, and coarctation of the aorta.
A 26-year-old p... | BISOPROLOL, DIAMORPHINE, FUROSEMIDE | DrugsGivenReaction | CC BY-NC | 32434290 | 20,992,015 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Low birth weight baby'. | Anesthetic management of a parturient with Shone's syndrome -a case report with review of literature.
Shone's syndrome is a rare complex congenital cardiac condition, characterized by a supra-valvular mitral ring, parachute deformity of the mitral valve, aortic stenosis, and coarctation of the aorta.
A 26-year-old p... | BISOPROLOL, BUPIVACAINE, CALCIUM CHLORIDE\POTASSIUM CHLORIDE\SODIUM CHLORIDE\SODIUM LACTATE, DIAMORPHINE, FUROSEMIDE, MAGNESIUM, OXYTOCIN, PHENYLEPHRINE HYDROCHLORIDE, POTASSIUM CHLORIDE, ROPIVACAINE, TINZAPARIN | DrugsGivenReaction | CC BY-NC | 32434290 | 20,960,163 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Maternal exposure during pregnancy'. | Anesthetic management of a parturient with Shone's syndrome -a case report with review of literature.
Shone's syndrome is a rare complex congenital cardiac condition, characterized by a supra-valvular mitral ring, parachute deformity of the mitral valve, aortic stenosis, and coarctation of the aorta.
A 26-year-old p... | BISOPROLOL, BUPIVACAINE, CALCIUM CHLORIDE\POTASSIUM CHLORIDE\SODIUM CHLORIDE\SODIUM LACTATE, DIAMORPHINE, FUROSEMIDE, MAGNESIUM, OXYTOCIN, PHENYLEPHRINE HYDROCHLORIDE, POTASSIUM CHLORIDE, ROPIVACAINE, TINZAPARIN | DrugsGivenReaction | CC BY-NC | 32434290 | 20,945,322 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Anesthetic management of a parturient with Shone's syndrome -a case report with review of literature.
Shone's syndrome is a rare complex congenital cardiac condition, characterized by a supra-valvular mitral ring, parachute deformity of the mitral valve, aortic stenosis, and coarctation of the aorta.
A 26-year-old p... | BISOPROLOL, BUPIVACAINE, CALCIUM CHLORIDE\POTASSIUM CHLORIDE\SODIUM CHLORIDE\SODIUM LACTATE, DIAMORPHINE, FUROSEMIDE, MAGNESIUM, OXYTOCIN, PHENYLEPHRINE HYDROCHLORIDE, POTASSIUM CHLORIDE, ROPIVACAINE, TINZAPARIN | DrugsGivenReaction | CC BY-NC | 32434290 | 20,945,322 | 2021-08 |
What was the administration route of drug 'CALCIUM CHLORIDE\POTASSIUM CHLORIDE\SODIUM CHLORIDE\SODIUM LACTATE'? | Anesthetic management of a parturient with Shone's syndrome -a case report with review of literature.
Shone's syndrome is a rare complex congenital cardiac condition, characterized by a supra-valvular mitral ring, parachute deformity of the mitral valve, aortic stenosis, and coarctation of the aorta.
A 26-year-old p... | Transplacental | DrugAdministrationRoute | CC BY-NC | 32434290 | 20,960,163 | 2021-08 |
What was the administration route of drug 'ROPIVACAINE'? | Anesthetic management of a parturient with Shone's syndrome -a case report with review of literature.
Shone's syndrome is a rare complex congenital cardiac condition, characterized by a supra-valvular mitral ring, parachute deformity of the mitral valve, aortic stenosis, and coarctation of the aorta.
A 26-year-old p... | Transplacental | DrugAdministrationRoute | CC BY-NC | 32434290 | 20,960,163 | 2021-08 |
What was the dosage of drug 'MAGNESIUM'? | Anesthetic management of a parturient with Shone's syndrome -a case report with review of literature.
Shone's syndrome is a rare complex congenital cardiac condition, characterized by a supra-valvular mitral ring, parachute deformity of the mitral valve, aortic stenosis, and coarctation of the aorta.
A 26-year-old p... | MATERNAL EXPOSURE DURING PREGNANCY: UNK | DrugDosageText | CC BY-NC | 32434290 | 20,960,163 | 2021-08 |
What was the dosage of drug 'POTASSIUM CHLORIDE'? | Anesthetic management of a parturient with Shone's syndrome -a case report with review of literature.
Shone's syndrome is a rare complex congenital cardiac condition, characterized by a supra-valvular mitral ring, parachute deformity of the mitral valve, aortic stenosis, and coarctation of the aorta.
A 26-year-old p... | MATERNAL EXPOSURE DURING PREGNANCY: UNK | DrugDosageText | CC BY-NC | 32434290 | 20,960,163 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Exposure during pregnancy'. | Subendocardial stress in pre-eclampsia.
A primigravida 26-year-old woman who had developed pre-eclampsia with malignant hypertension at 30 weeks of gestation suffered acute myocardial infarction two days postpartum. Electrocardiogram demonstrated diffuse ST-segment depression suggestive of subendocardial ischemia. Echo... | HYDRALAZINE HYDROCHLORIDE, LABETALOL HYDROCHLORIDE, METHYLDOPA, NIFEDIPINE | DrugsGivenReaction | CC BY | 32501623 | 18,932,064 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Foetal distress syndrome'. | Subendocardial stress in pre-eclampsia.
A primigravida 26-year-old woman who had developed pre-eclampsia with malignant hypertension at 30 weeks of gestation suffered acute myocardial infarction two days postpartum. Electrocardiogram demonstrated diffuse ST-segment depression suggestive of subendocardial ischemia. Echo... | HYDRALAZINE HYDROCHLORIDE, LABETALOL HYDROCHLORIDE, METHYLDOPA, NIFEDIPINE | DrugsGivenReaction | CC BY | 32501623 | 18,962,298 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Foetal exposure during pregnancy'. | Subendocardial stress in pre-eclampsia.
A primigravida 26-year-old woman who had developed pre-eclampsia with malignant hypertension at 30 weeks of gestation suffered acute myocardial infarction two days postpartum. Electrocardiogram demonstrated diffuse ST-segment depression suggestive of subendocardial ischemia. Echo... | HYDRALAZINE HYDROCHLORIDE, LABETALOL HYDROCHLORIDE, METHYLDOPA, NIFEDIPINE | DrugsGivenReaction | CC BY | 32501623 | 18,962,298 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Foetal growth restriction'. | Subendocardial stress in pre-eclampsia.
A primigravida 26-year-old woman who had developed pre-eclampsia with malignant hypertension at 30 weeks of gestation suffered acute myocardial infarction two days postpartum. Electrocardiogram demonstrated diffuse ST-segment depression suggestive of subendocardial ischemia. Echo... | HYDRALAZINE HYDROCHLORIDE, LABETALOL HYDROCHLORIDE, METHYLDOPA, NIFEDIPINE | DrugsGivenReaction | CC BY | 32501623 | 18,932,064 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Live birth'. | Subendocardial stress in pre-eclampsia.
A primigravida 26-year-old woman who had developed pre-eclampsia with malignant hypertension at 30 weeks of gestation suffered acute myocardial infarction two days postpartum. Electrocardiogram demonstrated diffuse ST-segment depression suggestive of subendocardial ischemia. Echo... | HYDRALAZINE HYDROCHLORIDE, LABETALOL\LABETALOL HYDROCHLORIDE, METHYLDOPA, NIFEDIPINE | DrugsGivenReaction | CC BY | 32501623 | 18,941,910 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Premature baby'. | Subendocardial stress in pre-eclampsia.
A primigravida 26-year-old woman who had developed pre-eclampsia with malignant hypertension at 30 weeks of gestation suffered acute myocardial infarction two days postpartum. Electrocardiogram demonstrated diffuse ST-segment depression suggestive of subendocardial ischemia. Echo... | HYDRALAZINE HYDROCHLORIDE, LABETALOL HYDROCHLORIDE, METHYLDOPA, NIFEDIPINE | DrugsGivenReaction | CC BY | 32501623 | 18,962,298 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Premature labour'. | Subendocardial stress in pre-eclampsia.
A primigravida 26-year-old woman who had developed pre-eclampsia with malignant hypertension at 30 weeks of gestation suffered acute myocardial infarction two days postpartum. Electrocardiogram demonstrated diffuse ST-segment depression suggestive of subendocardial ischemia. Echo... | HYDRALAZINE HYDROCHLORIDE, LABETALOL HYDROCHLORIDE, METHYLDOPA, NIFEDIPINE | DrugsGivenReaction | CC BY | 32501623 | 18,962,383 | 2021-01 |
What was the administration route of drug 'LABETALOL\LABETALOL HYDROCHLORIDE'? | Subendocardial stress in pre-eclampsia.
A primigravida 26-year-old woman who had developed pre-eclampsia with malignant hypertension at 30 weeks of gestation suffered acute myocardial infarction two days postpartum. Electrocardiogram demonstrated diffuse ST-segment depression suggestive of subendocardial ischemia. Echo... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 32501623 | 18,941,910 | 2021-01 |
What was the administration route of drug 'METHYLDOPA'? | Subendocardial stress in pre-eclampsia.
A primigravida 26-year-old woman who had developed pre-eclampsia with malignant hypertension at 30 weeks of gestation suffered acute myocardial infarction two days postpartum. Electrocardiogram demonstrated diffuse ST-segment depression suggestive of subendocardial ischemia. Echo... | Transplacental | DrugAdministrationRoute | CC BY | 32501623 | 18,962,298 | 2021-01 |
What was the dosage of drug 'LABETALOL HYDROCHLORIDE'? | Subendocardial stress in pre-eclampsia.
A primigravida 26-year-old woman who had developed pre-eclampsia with malignant hypertension at 30 weeks of gestation suffered acute myocardial infarction two days postpartum. Electrocardiogram demonstrated diffuse ST-segment depression suggestive of subendocardial ischemia. Echo... | MAXIMAL DOSES | DrugDosageText | CC BY | 32501623 | 18,932,064 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Athetosis'. | Electroconvulsive therapy for severe depression, psychosis and chorea in a patient with Huntington's disease: case report and review of the literature.
OBJECTIVE
The psychiatric manifestations of Huntington's disease are myriad and difficult to control. The use of electroconvulsive therapy (ECT) is not commonly conside... | CITALOPRAM HYDROBROMIDE, OLANZAPINE, SERTRALINE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 32513333 | 19,281,931 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Electroconvulsive therapy for severe depression, psychosis and chorea in a patient with Huntington's disease: case report and review of the literature.
OBJECTIVE
The psychiatric manifestations of Huntington's disease are myriad and difficult to control. The use of electroconvulsive therapy (ECT) is not commonly conside... | CITALOPRAM HYDROBROMIDE, OLANZAPINE, SERTRALINE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 32513333 | 19,281,931 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Electroconvulsive therapy for severe depression, psychosis and chorea in a patient with Huntington's disease: case report and review of the literature.
OBJECTIVE
The psychiatric manifestations of Huntington's disease are myriad and difficult to control. The use of electroconvulsive therapy (ECT) is not commonly conside... | OLANZAPINE, SERTRALINE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 32513333 | 19,278,589 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fall'. | Electroconvulsive therapy for severe depression, psychosis and chorea in a patient with Huntington's disease: case report and review of the literature.
OBJECTIVE
The psychiatric manifestations of Huntington's disease are myriad and difficult to control. The use of electroconvulsive therapy (ECT) is not commonly conside... | CITALOPRAM HYDROBROMIDE, OLANZAPINE, SERTRALINE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 32513333 | 19,281,931 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Somnolence'. | Electroconvulsive therapy for severe depression, psychosis and chorea in a patient with Huntington's disease: case report and review of the literature.
OBJECTIVE
The psychiatric manifestations of Huntington's disease are myriad and difficult to control. The use of electroconvulsive therapy (ECT) is not commonly conside... | CITALOPRAM HYDROBROMIDE, OLANZAPINE, SERTRALINE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 32513333 | 19,281,931 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Arthralgia'. | PCSK9 Inhibitors in a German Single-Center Clinical Practice: Real-World Treatment of Patients at High Cardiovascular Risk Over 68 Weeks.
OBJECTIVE
Several the use of proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) for patients at high/very high cardiovascular risk who are inadequately treated with ma... | EVOLOCUMAB | DrugsGivenReaction | CC BY-NC | 32514867 | 17,938,316 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Back pain'. | PCSK9 Inhibitors in a German Single-Center Clinical Practice: Real-World Treatment of Patients at High Cardiovascular Risk Over 68 Weeks.
OBJECTIVE
Several the use of proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) for patients at high/very high cardiovascular risk who are inadequately treated with ma... | EVOLOCUMAB | DrugsGivenReaction | CC BY-NC | 32514867 | 17,938,316 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiovascular disorder'. | PCSK9 Inhibitors in a German Single-Center Clinical Practice: Real-World Treatment of Patients at High Cardiovascular Risk Over 68 Weeks.
OBJECTIVE
Several the use of proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) for patients at high/very high cardiovascular risk who are inadequately treated with ma... | EVOLOCUMAB | DrugsGivenReaction | CC BY-NC | 32514867 | 17,938,316 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fatigue'. | PCSK9 Inhibitors in a German Single-Center Clinical Practice: Real-World Treatment of Patients at High Cardiovascular Risk Over 68 Weeks.
OBJECTIVE
Several the use of proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) for patients at high/very high cardiovascular risk who are inadequately treated with ma... | EVOLOCUMAB | DrugsGivenReaction | CC BY-NC | 32514867 | 17,938,316 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Headache'. | PCSK9 Inhibitors in a German Single-Center Clinical Practice: Real-World Treatment of Patients at High Cardiovascular Risk Over 68 Weeks.
OBJECTIVE
Several the use of proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) for patients at high/very high cardiovascular risk who are inadequately treated with ma... | EVOLOCUMAB | DrugsGivenReaction | CC BY-NC | 32514867 | 17,938,316 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Myalgia'. | PCSK9 Inhibitors in a German Single-Center Clinical Practice: Real-World Treatment of Patients at High Cardiovascular Risk Over 68 Weeks.
OBJECTIVE
Several the use of proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) for patients at high/very high cardiovascular risk who are inadequately treated with ma... | EVOLOCUMAB | DrugsGivenReaction | CC BY-NC | 32514867 | 17,938,316 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nausea'. | PCSK9 Inhibitors in a German Single-Center Clinical Practice: Real-World Treatment of Patients at High Cardiovascular Risk Over 68 Weeks.
OBJECTIVE
Several the use of proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) for patients at high/very high cardiovascular risk who are inadequately treated with ma... | EVOLOCUMAB | DrugsGivenReaction | CC BY-NC | 32514867 | 17,938,316 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Oropharyngeal pain'. | PCSK9 Inhibitors in a German Single-Center Clinical Practice: Real-World Treatment of Patients at High Cardiovascular Risk Over 68 Weeks.
OBJECTIVE
Several the use of proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) for patients at high/very high cardiovascular risk who are inadequately treated with ma... | EVOLOCUMAB | DrugsGivenReaction | CC BY-NC | 32514867 | 17,938,316 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pruritus'. | PCSK9 Inhibitors in a German Single-Center Clinical Practice: Real-World Treatment of Patients at High Cardiovascular Risk Over 68 Weeks.
OBJECTIVE
Several the use of proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) for patients at high/very high cardiovascular risk who are inadequately treated with ma... | EVOLOCUMAB | DrugsGivenReaction | CC BY-NC | 32514867 | 17,938,316 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rhinitis'. | PCSK9 Inhibitors in a German Single-Center Clinical Practice: Real-World Treatment of Patients at High Cardiovascular Risk Over 68 Weeks.
OBJECTIVE
Several the use of proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) for patients at high/very high cardiovascular risk who are inadequately treated with ma... | EVOLOCUMAB | DrugsGivenReaction | CC BY-NC | 32514867 | 17,938,316 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vertigo'. | PCSK9 Inhibitors in a German Single-Center Clinical Practice: Real-World Treatment of Patients at High Cardiovascular Risk Over 68 Weeks.
OBJECTIVE
Several the use of proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) for patients at high/very high cardiovascular risk who are inadequately treated with ma... | EVOLOCUMAB | DrugsGivenReaction | CC BY-NC | 32514867 | 17,938,316 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blood disorder'. | Management of lithium dosing around delivery: An observational study.
Recommendations on lithium dosing around delivery vary, with several guidelines suggesting that lithium should be discontinued prior to delivery. We aimed to evaluate the validity of these recommendations by investigating 1) maternal lithium blood le... | LITHIUM CARBONATE | DrugsGivenReaction | CC BY | 32526071 | 18,040,404 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiovascular insufficiency'. | Management of lithium dosing around delivery: An observational study.
Recommendations on lithium dosing around delivery vary, with several guidelines suggesting that lithium should be discontinued prior to delivery. We aimed to evaluate the validity of these recommendations by investigating 1) maternal lithium blood le... | LITHIUM CARBONATE | DrugsGivenReaction | CC BY | 32526071 | 18,040,404 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Foetal distress syndrome'. | Management of lithium dosing around delivery: An observational study.
Recommendations on lithium dosing around delivery vary, with several guidelines suggesting that lithium should be discontinued prior to delivery. We aimed to evaluate the validity of these recommendations by investigating 1) maternal lithium blood le... | LITHIUM CARBONATE | DrugsGivenReaction | CC BY | 32526071 | 18,040,404 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Foetal exposure during pregnancy'. | Management of lithium dosing around delivery: An observational study.
Recommendations on lithium dosing around delivery vary, with several guidelines suggesting that lithium should be discontinued prior to delivery. We aimed to evaluate the validity of these recommendations by investigating 1) maternal lithium blood le... | LITHIUM CARBONATE | DrugsGivenReaction | CC BY | 32526071 | 18,040,404 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Metabolic disorder'. | Management of lithium dosing around delivery: An observational study.
Recommendations on lithium dosing around delivery vary, with several guidelines suggesting that lithium should be discontinued prior to delivery. We aimed to evaluate the validity of these recommendations by investigating 1) maternal lithium blood le... | LITHIUM CARBONATE | DrugsGivenReaction | CC BY | 32526071 | 18,040,404 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neonatal gastrointestinal disorder'. | Management of lithium dosing around delivery: An observational study.
Recommendations on lithium dosing around delivery vary, with several guidelines suggesting that lithium should be discontinued prior to delivery. We aimed to evaluate the validity of these recommendations by investigating 1) maternal lithium blood le... | LITHIUM CARBONATE | DrugsGivenReaction | CC BY | 32526071 | 18,040,404 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neonatal infection'. | Management of lithium dosing around delivery: An observational study.
Recommendations on lithium dosing around delivery vary, with several guidelines suggesting that lithium should be discontinued prior to delivery. We aimed to evaluate the validity of these recommendations by investigating 1) maternal lithium blood le... | LITHIUM CARBONATE | DrugsGivenReaction | CC BY | 32526071 | 18,040,404 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nervous system disorder'. | Management of lithium dosing around delivery: An observational study.
Recommendations on lithium dosing around delivery vary, with several guidelines suggesting that lithium should be discontinued prior to delivery. We aimed to evaluate the validity of these recommendations by investigating 1) maternal lithium blood le... | LITHIUM CARBONATE | DrugsGivenReaction | CC BY | 32526071 | 18,040,404 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Respiratory disorder neonatal'. | Management of lithium dosing around delivery: An observational study.
Recommendations on lithium dosing around delivery vary, with several guidelines suggesting that lithium should be discontinued prior to delivery. We aimed to evaluate the validity of these recommendations by investigating 1) maternal lithium blood le... | LITHIUM CARBONATE | DrugsGivenReaction | CC BY | 32526071 | 18,040,404 | 2021-02 |
What was the administration route of drug 'LITHIUM CARBONATE'? | Management of lithium dosing around delivery: An observational study.
Recommendations on lithium dosing around delivery vary, with several guidelines suggesting that lithium should be discontinued prior to delivery. We aimed to evaluate the validity of these recommendations by investigating 1) maternal lithium blood le... | Transplacental | DrugAdministrationRoute | CC BY | 32526071 | 18,040,404 | 2021-02 |
What was the administration route of drug 'PAMIDRONATE DISODIUM'? | Bone mineral density improves during 2 years of treatment with bisphosphonates in patients with ankylosing spondylitis.
To evaluate whether 2 years of treatment with bisphosphonates in combination with calcium/vitamin D supplements has an effect on lumbar spine and hip bone mineral density (BMD) in ankylosing spondylit... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 32530102 | 18,066,134 | 2021-02 |
What was the administration route of drug 'HYDROXYCHLOROQUINE'? | Sudden cardiac death in COVID-19 patients, a report of three cases.
The mortality rate of coronavirus disease-19 (COVID-19) has been reported as 1-6% in most studies. The cause of most deaths has been acute pneumonia. Nevertheless, it has been noted that cardiovascular failure can also lead to death. Three COVID-19 pat... | Oral | DrugAdministrationRoute | CC BY | 32615807 | 18,753,038 | 2021-01 |
What was the administration route of drug 'LOPINAVIR\RITONAVIR'? | Sudden cardiac death in COVID-19 patients, a report of three cases.
The mortality rate of coronavirus disease-19 (COVID-19) has been reported as 1-6% in most studies. The cause of most deaths has been acute pneumonia. Nevertheless, it has been noted that cardiovascular failure can also lead to death. Three COVID-19 pat... | Oral | DrugAdministrationRoute | CC BY | 32615807 | 18,753,038 | 2021-01 |
What was the dosage of drug 'AZITHROMYCIN ANHYDROUS'? | Sudden cardiac death in COVID-19 patients, a report of three cases.
The mortality rate of coronavirus disease-19 (COVID-19) has been reported as 1-6% in most studies. The cause of most deaths has been acute pneumonia. Nevertheless, it has been noted that cardiovascular failure can also lead to death. Three COVID-19 pat... | UNKNOWN | DrugDosageText | CC BY | 32615807 | 18,786,710 | 2021-01 |
What was the dosage of drug 'HYDROXYCHLOROQUINE'? | Sudden cardiac death in COVID-19 patients, a report of three cases.
The mortality rate of coronavirus disease-19 (COVID-19) has been reported as 1-6% in most studies. The cause of most deaths has been acute pneumonia. Nevertheless, it has been noted that cardiovascular failure can also lead to death. Three COVID-19 pat... | UNKNOWN | DrugDosageText | CC BY | 32615807 | 18,786,710 | 2021-01 |
What was the dosage of drug 'LOPINAVIR\RITONAVIR'? | Sudden cardiac death in COVID-19 patients, a report of three cases.
The mortality rate of coronavirus disease-19 (COVID-19) has been reported as 1-6% in most studies. The cause of most deaths has been acute pneumonia. Nevertheless, it has been noted that cardiovascular failure can also lead to death. Three COVID-19 pat... | UNKNOWN | DrugDosageText | CC BY | 32615807 | 18,786,710 | 2021-01 |
What was the dosage of drug 'OSELTAMIVIR'? | Sudden cardiac death in COVID-19 patients, a report of three cases.
The mortality rate of coronavirus disease-19 (COVID-19) has been reported as 1-6% in most studies. The cause of most deaths has been acute pneumonia. Nevertheless, it has been noted that cardiovascular failure can also lead to death. Three COVID-19 pat... | UNKNOWN | DrugDosageText | CC BY | 32615807 | 18,786,710 | 2021-01 |
What was the outcome of reaction 'Cardiac arrest'? | Sudden cardiac death in COVID-19 patients, a report of three cases.
The mortality rate of coronavirus disease-19 (COVID-19) has been reported as 1-6% in most studies. The cause of most deaths has been acute pneumonia. Nevertheless, it has been noted that cardiovascular failure can also lead to death. Three COVID-19 pat... | Fatal | ReactionOutcome | CC BY | 32615807 | 18,820,507 | 2021-01 |
What was the outcome of reaction 'Electrocardiogram QT prolonged'? | Sudden cardiac death in COVID-19 patients, a report of three cases.
The mortality rate of coronavirus disease-19 (COVID-19) has been reported as 1-6% in most studies. The cause of most deaths has been acute pneumonia. Nevertheless, it has been noted that cardiovascular failure can also lead to death. Three COVID-19 pat... | Fatal | ReactionOutcome | CC BY | 32615807 | 18,820,507 | 2021-01 |
What was the outcome of reaction 'Torsade de pointes'? | Sudden cardiac death in COVID-19 patients, a report of three cases.
The mortality rate of coronavirus disease-19 (COVID-19) has been reported as 1-6% in most studies. The cause of most deaths has been acute pneumonia. Nevertheless, it has been noted that cardiovascular failure can also lead to death. Three COVID-19 pat... | Fatal | ReactionOutcome | CC BY | 32615807 | 18,820,507 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Human herpesvirus 6 encephalitis'. | Human herpesvirus 6B encephalitis in a liver transplant recipient: A case report and review of the literature.
Human herpesvirus 6B (HHV-6B) encephalitis in a liver transplant recipient is rarely reported. In this report, we presented a case of HHV-6B encephalitis in a liver transplant recipient and reviewed the releva... | SIROLIMUS, TACROLIMUS | DrugsGivenReaction | CC BY | 32638491 | 18,048,674 | 2021-02 |
What was the outcome of reaction 'Human herpesvirus 6 encephalitis'? | Human herpesvirus 6B encephalitis in a liver transplant recipient: A case report and review of the literature.
Human herpesvirus 6B (HHV-6B) encephalitis in a liver transplant recipient is rarely reported. In this report, we presented a case of HHV-6B encephalitis in a liver transplant recipient and reviewed the releva... | Recovered | ReactionOutcome | CC BY | 32638491 | 18,048,674 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute monocytic leukaemia'. | HEMOPHAGOCYTOSIS BY BLASTS IN A CHILD WITH ACUTE MONOCYTIC LEUKEMIA AFTER CHEMOTHERAPY.
OBJECTIVE
To describe the case of a child who presented hemophagocytic lymphohistiocytosis (HLH) associated with acute monocytic leukemia after chemotherapy, with hemophagocytosis caused by leukemic cells.
METHODS
In a university ... | CYTARABINE, ETOPOSIDE, FILGRASTIM, FLUDARABINE PHOSPHATE, IDARUBICIN | DrugsGivenReaction | CC BY | 32638943 | 18,428,155 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cytomegalovirus infection'. | HEMOPHAGOCYTOSIS BY BLASTS IN A CHILD WITH ACUTE MONOCYTIC LEUKEMIA AFTER CHEMOTHERAPY.
OBJECTIVE
To describe the case of a child who presented hemophagocytic lymphohistiocytosis (HLH) associated with acute monocytic leukemia after chemotherapy, with hemophagocytosis caused by leukemic cells.
METHODS
In a university ... | CYTARABINE, ETOPOSIDE, FILGRASTIM, FLUDARABINE PHOSPHATE, IDARUBICIN, MERCAPTOPURINE, MITOXANTRONE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 32638943 | 18,471,753 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Death'. | HEMOPHAGOCYTOSIS BY BLASTS IN A CHILD WITH ACUTE MONOCYTIC LEUKEMIA AFTER CHEMOTHERAPY.
OBJECTIVE
To describe the case of a child who presented hemophagocytic lymphohistiocytosis (HLH) associated with acute monocytic leukemia after chemotherapy, with hemophagocytosis caused by leukemic cells.
METHODS
In a university ... | CYTARABINE, ETOPOSIDE, FILGRASTIM, FLUDARABINE PHOSPHATE, IDARUBICIN, MERCAPTOPURINE, MITOXANTRONE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 32638943 | 18,471,753 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Epstein-Barr virus infection'. | HEMOPHAGOCYTOSIS BY BLASTS IN A CHILD WITH ACUTE MONOCYTIC LEUKEMIA AFTER CHEMOTHERAPY.
OBJECTIVE
To describe the case of a child who presented hemophagocytic lymphohistiocytosis (HLH) associated with acute monocytic leukemia after chemotherapy, with hemophagocytosis caused by leukemic cells.
METHODS
In a university ... | CYTARABINE, ETOPOSIDE, FILGRASTIM, FLUDARABINE PHOSPHATE, IDARUBICIN, MERCAPTOPURINE, MITOXANTRONE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 32638943 | 18,471,753 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neutropenia'. | HEMOPHAGOCYTOSIS BY BLASTS IN A CHILD WITH ACUTE MONOCYTIC LEUKEMIA AFTER CHEMOTHERAPY.
OBJECTIVE
To describe the case of a child who presented hemophagocytic lymphohistiocytosis (HLH) associated with acute monocytic leukemia after chemotherapy, with hemophagocytosis caused by leukemic cells.
METHODS
In a university ... | CYTARABINE, ETOPOSIDE, FILGRASTIM, FLUDARABINE PHOSPHATE, IDARUBICIN | DrugsGivenReaction | CC BY | 32638943 | 18,428,155 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Palpitations'. | HEMOPHAGOCYTOSIS BY BLASTS IN A CHILD WITH ACUTE MONOCYTIC LEUKEMIA AFTER CHEMOTHERAPY.
OBJECTIVE
To describe the case of a child who presented hemophagocytic lymphohistiocytosis (HLH) associated with acute monocytic leukemia after chemotherapy, with hemophagocytosis caused by leukemic cells.
METHODS
In a university ... | CYTARABINE, ETOPOSIDE, FILGRASTIM, FLUDARABINE PHOSPHATE, IDARUBICIN | DrugsGivenReaction | CC BY | 32638943 | 18,428,155 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pyrexia'. | HEMOPHAGOCYTOSIS BY BLASTS IN A CHILD WITH ACUTE MONOCYTIC LEUKEMIA AFTER CHEMOTHERAPY.
OBJECTIVE
To describe the case of a child who presented hemophagocytic lymphohistiocytosis (HLH) associated with acute monocytic leukemia after chemotherapy, with hemophagocytosis caused by leukemic cells.
METHODS
In a university ... | CYTARABINE, ETOPOSIDE, FILGRASTIM, FLUDARABINE PHOSPHATE, IDARUBICIN | DrugsGivenReaction | CC BY | 32638943 | 18,428,155 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Splenomegaly'. | HEMOPHAGOCYTOSIS BY BLASTS IN A CHILD WITH ACUTE MONOCYTIC LEUKEMIA AFTER CHEMOTHERAPY.
OBJECTIVE
To describe the case of a child who presented hemophagocytic lymphohistiocytosis (HLH) associated with acute monocytic leukemia after chemotherapy, with hemophagocytosis caused by leukemic cells.
METHODS
In a university ... | CEFEPIME HYDROCHLORIDE, CEFUROXIME, CYTARABINE, ETOPOSIDE, FILGRASTIM, FLUDARABINE PHOSPHATE, IDARUBICIN, MERCAPTOPURINE, MITOXANTRONE HYDROCHLORIDE, VANCOMYCIN | DrugsGivenReaction | CC BY | 32638943 | 18,509,828 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Staphylococcal infection'. | HEMOPHAGOCYTOSIS BY BLASTS IN A CHILD WITH ACUTE MONOCYTIC LEUKEMIA AFTER CHEMOTHERAPY.
OBJECTIVE
To describe the case of a child who presented hemophagocytic lymphohistiocytosis (HLH) associated with acute monocytic leukemia after chemotherapy, with hemophagocytosis caused by leukemic cells.
METHODS
In a university ... | CYTARABINE, ETOPOSIDE, FILGRASTIM, FLUDARABINE PHOSPHATE, IDARUBICIN, MERCAPTOPURINE, MITOXANTRONE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 32638943 | 18,471,753 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Toxoplasmosis'. | HEMOPHAGOCYTOSIS BY BLASTS IN A CHILD WITH ACUTE MONOCYTIC LEUKEMIA AFTER CHEMOTHERAPY.
OBJECTIVE
To describe the case of a child who presented hemophagocytic lymphohistiocytosis (HLH) associated with acute monocytic leukemia after chemotherapy, with hemophagocytosis caused by leukemic cells.
METHODS
In a university ... | CYTARABINE, ETOPOSIDE, FILGRASTIM, FLUDARABINE PHOSPHATE, IDARUBICIN, MERCAPTOPURINE, MITOXANTRONE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 32638943 | 18,471,753 | 2021 |
What was the dosage of drug 'FILGRASTIM'? | HEMOPHAGOCYTOSIS BY BLASTS IN A CHILD WITH ACUTE MONOCYTIC LEUKEMIA AFTER CHEMOTHERAPY.
OBJECTIVE
To describe the case of a child who presented hemophagocytic lymphohistiocytosis (HLH) associated with acute monocytic leukemia after chemotherapy, with hemophagocytosis caused by leukemic cells.
METHODS
In a university ... | UNK UNK, CYCLIC | DrugDosageText | CC BY | 32638943 | 18,479,665 | 2021 |
What was the dosage of drug 'IDARUBICIN HYDROCHLORIDE'? | HEMOPHAGOCYTOSIS BY BLASTS IN A CHILD WITH ACUTE MONOCYTIC LEUKEMIA AFTER CHEMOTHERAPY.
OBJECTIVE
To describe the case of a child who presented hemophagocytic lymphohistiocytosis (HLH) associated with acute monocytic leukemia after chemotherapy, with hemophagocytosis caused by leukemic cells.
METHODS
In a university ... | UNK UNK, CYCLIC | DrugDosageText | CC BY | 32638943 | 18,479,665 | 2021 |
What was the outcome of reaction 'Acute monocytic leukaemia'? | HEMOPHAGOCYTOSIS BY BLASTS IN A CHILD WITH ACUTE MONOCYTIC LEUKEMIA AFTER CHEMOTHERAPY.
OBJECTIVE
To describe the case of a child who presented hemophagocytic lymphohistiocytosis (HLH) associated with acute monocytic leukemia after chemotherapy, with hemophagocytosis caused by leukemic cells.
METHODS
In a university ... | Fatal | ReactionOutcome | CC BY | 32638943 | 18,428,155 | 2021 |
What was the outcome of reaction 'Cytomegalovirus infection'? | HEMOPHAGOCYTOSIS BY BLASTS IN A CHILD WITH ACUTE MONOCYTIC LEUKEMIA AFTER CHEMOTHERAPY.
OBJECTIVE
To describe the case of a child who presented hemophagocytic lymphohistiocytosis (HLH) associated with acute monocytic leukemia after chemotherapy, with hemophagocytosis caused by leukemic cells.
METHODS
In a university ... | Not recovered | ReactionOutcome | CC BY | 32638943 | 18,471,753 | 2021 |
What was the outcome of reaction 'Death'? | HEMOPHAGOCYTOSIS BY BLASTS IN A CHILD WITH ACUTE MONOCYTIC LEUKEMIA AFTER CHEMOTHERAPY.
OBJECTIVE
To describe the case of a child who presented hemophagocytic lymphohistiocytosis (HLH) associated with acute monocytic leukemia after chemotherapy, with hemophagocytosis caused by leukemic cells.
METHODS
In a university ... | Fatal | ReactionOutcome | CC BY | 32638943 | 18,471,753 | 2021 |
What was the outcome of reaction 'Epstein-Barr virus infection'? | HEMOPHAGOCYTOSIS BY BLASTS IN A CHILD WITH ACUTE MONOCYTIC LEUKEMIA AFTER CHEMOTHERAPY.
OBJECTIVE
To describe the case of a child who presented hemophagocytic lymphohistiocytosis (HLH) associated with acute monocytic leukemia after chemotherapy, with hemophagocytosis caused by leukemic cells.
METHODS
In a university ... | Not recovered | ReactionOutcome | CC BY | 32638943 | 18,471,753 | 2021 |
What was the outcome of reaction 'Haemophagocytic lymphohistiocytosis'? | HEMOPHAGOCYTOSIS BY BLASTS IN A CHILD WITH ACUTE MONOCYTIC LEUKEMIA AFTER CHEMOTHERAPY.
OBJECTIVE
To describe the case of a child who presented hemophagocytic lymphohistiocytosis (HLH) associated with acute monocytic leukemia after chemotherapy, with hemophagocytosis caused by leukemic cells.
METHODS
In a university ... | Not recovered | ReactionOutcome | CC BY | 32638943 | 18,509,828 | 2021 |
What was the outcome of reaction 'Staphylococcal infection'? | HEMOPHAGOCYTOSIS BY BLASTS IN A CHILD WITH ACUTE MONOCYTIC LEUKEMIA AFTER CHEMOTHERAPY.
OBJECTIVE
To describe the case of a child who presented hemophagocytic lymphohistiocytosis (HLH) associated with acute monocytic leukemia after chemotherapy, with hemophagocytosis caused by leukemic cells.
METHODS
In a university ... | Not recovered | ReactionOutcome | CC BY | 32638943 | 18,471,753 | 2021 |
What was the outcome of reaction 'Toxoplasmosis'? | HEMOPHAGOCYTOSIS BY BLASTS IN A CHILD WITH ACUTE MONOCYTIC LEUKEMIA AFTER CHEMOTHERAPY.
OBJECTIVE
To describe the case of a child who presented hemophagocytic lymphohistiocytosis (HLH) associated with acute monocytic leukemia after chemotherapy, with hemophagocytosis caused by leukemic cells.
METHODS
In a university ... | Not recovered | ReactionOutcome | CC BY | 32638943 | 18,471,753 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Accidental overdose'. | SEVERE ACUTE TOXIC EXPOSURES IN CHILDREN AND ADOLESCENTS: CASE SERIES.
OBJECTIVE
To describe a case series of severe acute toxic exposures (SATE) in individuals <20 years old followed-up by a regional Poison Control Center (PCC).
METHODS
Descriptive cross-sectional study. All patients who were <20yo and classified as... | CLONAZEPAM, HALOPERIDOL, PROMETHAZINE HYDROCHLORIDE, VALPROIC ACID | DrugsGivenReaction | CC BY | 32638947 | 18,538,418 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute kidney injury'. | SEVERE ACUTE TOXIC EXPOSURES IN CHILDREN AND ADOLESCENTS: CASE SERIES.
OBJECTIVE
To describe a case series of severe acute toxic exposures (SATE) in individuals <20 years old followed-up by a regional Poison Control Center (PCC).
METHODS
Descriptive cross-sectional study. All patients who were <20yo and classified as... | CLONAZEPAM, HALOPERIDOL, PROMETHAZINE HYDROCHLORIDE, VALPROIC ACID | DrugsGivenReaction | CC BY | 32638947 | 18,538,418 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Bradycardia'. | SEVERE ACUTE TOXIC EXPOSURES IN CHILDREN AND ADOLESCENTS: CASE SERIES.
OBJECTIVE
To describe a case series of severe acute toxic exposures (SATE) in individuals <20 years old followed-up by a regional Poison Control Center (PCC).
METHODS
Descriptive cross-sectional study. All patients who were <20yo and classified as... | CLONAZEPAM, HALOPERIDOL, PROMETHAZINE HYDROCHLORIDE, VALPROIC ACID | DrugsGivenReaction | CC BY | 32638947 | 18,538,418 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Brain death'. | SEVERE ACUTE TOXIC EXPOSURES IN CHILDREN AND ADOLESCENTS: CASE SERIES.
OBJECTIVE
To describe a case series of severe acute toxic exposures (SATE) in individuals <20 years old followed-up by a regional Poison Control Center (PCC).
METHODS
Descriptive cross-sectional study. All patients who were <20yo and classified as... | CLONAZEPAM, HALOPERIDOL, PROMETHAZINE HYDROCHLORIDE, VALPROIC ACID | DrugsGivenReaction | CC BY | 32638947 | 18,538,418 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Death'. | SEVERE ACUTE TOXIC EXPOSURES IN CHILDREN AND ADOLESCENTS: CASE SERIES.
OBJECTIVE
To describe a case series of severe acute toxic exposures (SATE) in individuals <20 years old followed-up by a regional Poison Control Center (PCC).
METHODS
Descriptive cross-sectional study. All patients who were <20yo and classified as... | CLONAZEPAM, HALOPERIDOL, PROMETHAZINE HYDROCHLORIDE, VALPROIC ACID | DrugsGivenReaction | CC BY | 32638947 | 18,475,028 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Depressed level of consciousness'. | SEVERE ACUTE TOXIC EXPOSURES IN CHILDREN AND ADOLESCENTS: CASE SERIES.
OBJECTIVE
To describe a case series of severe acute toxic exposures (SATE) in individuals <20 years old followed-up by a regional Poison Control Center (PCC).
METHODS
Descriptive cross-sectional study. All patients who were <20yo and classified as... | CLONAZEPAM, HALOPERIDOL, PROMETHAZINE HYDROCHLORIDE, VALPROIC ACID | DrugsGivenReaction | CC BY | 32638947 | 18,538,418 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Electrocardiogram QT prolonged'. | SEVERE ACUTE TOXIC EXPOSURES IN CHILDREN AND ADOLESCENTS: CASE SERIES.
OBJECTIVE
To describe a case series of severe acute toxic exposures (SATE) in individuals <20 years old followed-up by a regional Poison Control Center (PCC).
METHODS
Descriptive cross-sectional study. All patients who were <20yo and classified as... | CLONAZEPAM, HALOPERIDOL, PROMETHAZINE HYDROCHLORIDE, VALPROIC ACID | DrugsGivenReaction | CC BY | 32638947 | 18,538,418 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Epistaxis'. | SEVERE ACUTE TOXIC EXPOSURES IN CHILDREN AND ADOLESCENTS: CASE SERIES.
OBJECTIVE
To describe a case series of severe acute toxic exposures (SATE) in individuals <20 years old followed-up by a regional Poison Control Center (PCC).
METHODS
Descriptive cross-sectional study. All patients who were <20yo and classified as... | CLONAZEPAM, HALOPERIDOL, PROMETHAZINE HYDROCHLORIDE, VALPROIC ACID | DrugsGivenReaction | CC BY | 32638947 | 18,538,418 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Exposure to toxic agent'. | SEVERE ACUTE TOXIC EXPOSURES IN CHILDREN AND ADOLESCENTS: CASE SERIES.
OBJECTIVE
To describe a case series of severe acute toxic exposures (SATE) in individuals <20 years old followed-up by a regional Poison Control Center (PCC).
METHODS
Descriptive cross-sectional study. All patients who were <20yo and classified as... | CLONAZEPAM, HALOPERIDOL, PROMETHAZINE HYDROCHLORIDE, VALPROIC ACID | DrugsGivenReaction | CC BY | 32638947 | 18,475,028 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypoglycaemia'. | SEVERE ACUTE TOXIC EXPOSURES IN CHILDREN AND ADOLESCENTS: CASE SERIES.
OBJECTIVE
To describe a case series of severe acute toxic exposures (SATE) in individuals <20 years old followed-up by a regional Poison Control Center (PCC).
METHODS
Descriptive cross-sectional study. All patients who were <20yo and classified as... | CLONAZEPAM, HALOPERIDOL, PROMETHAZINE HYDROCHLORIDE, VALPROIC ACID | DrugsGivenReaction | CC BY | 32638947 | 18,538,418 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypothermia'. | SEVERE ACUTE TOXIC EXPOSURES IN CHILDREN AND ADOLESCENTS: CASE SERIES.
OBJECTIVE
To describe a case series of severe acute toxic exposures (SATE) in individuals <20 years old followed-up by a regional Poison Control Center (PCC).
METHODS
Descriptive cross-sectional study. All patients who were <20yo and classified as... | CLONAZEPAM, HALOPERIDOL, PROMETHAZINE HYDROCHLORIDE, VALPROIC ACID | DrugsGivenReaction | CC BY | 32638947 | 18,538,418 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Shock'. | SEVERE ACUTE TOXIC EXPOSURES IN CHILDREN AND ADOLESCENTS: CASE SERIES.
OBJECTIVE
To describe a case series of severe acute toxic exposures (SATE) in individuals <20 years old followed-up by a regional Poison Control Center (PCC).
METHODS
Descriptive cross-sectional study. All patients who were <20yo and classified as... | CLONAZEPAM, HALOPERIDOL, PROMETHAZINE HYDROCHLORIDE, VALPROIC ACID | DrugsGivenReaction | CC BY | 32638947 | 18,538,418 | 2021 |
What was the administration route of drug 'CLONAZEPAM'? | SEVERE ACUTE TOXIC EXPOSURES IN CHILDREN AND ADOLESCENTS: CASE SERIES.
OBJECTIVE
To describe a case series of severe acute toxic exposures (SATE) in individuals <20 years old followed-up by a regional Poison Control Center (PCC).
METHODS
Descriptive cross-sectional study. All patients who were <20yo and classified as... | Oral | DrugAdministrationRoute | CC BY | 32638947 | 18,538,418 | 2021 |
What was the administration route of drug 'HALOPERIDOL'? | SEVERE ACUTE TOXIC EXPOSURES IN CHILDREN AND ADOLESCENTS: CASE SERIES.
OBJECTIVE
To describe a case series of severe acute toxic exposures (SATE) in individuals <20 years old followed-up by a regional Poison Control Center (PCC).
METHODS
Descriptive cross-sectional study. All patients who were <20yo and classified as... | Oral | DrugAdministrationRoute | CC BY | 32638947 | 18,538,418 | 2021 |
What was the administration route of drug 'PROMETHAZINE HYDROCHLORIDE'? | SEVERE ACUTE TOXIC EXPOSURES IN CHILDREN AND ADOLESCENTS: CASE SERIES.
OBJECTIVE
To describe a case series of severe acute toxic exposures (SATE) in individuals <20 years old followed-up by a regional Poison Control Center (PCC).
METHODS
Descriptive cross-sectional study. All patients who were <20yo and classified as... | Oral | DrugAdministrationRoute | CC BY | 32638947 | 18,538,418 | 2021 |
What was the administration route of drug 'VALPROIC ACID'? | SEVERE ACUTE TOXIC EXPOSURES IN CHILDREN AND ADOLESCENTS: CASE SERIES.
OBJECTIVE
To describe a case series of severe acute toxic exposures (SATE) in individuals <20 years old followed-up by a regional Poison Control Center (PCC).
METHODS
Descriptive cross-sectional study. All patients who were <20yo and classified as... | Oral | DrugAdministrationRoute | CC BY | 32638947 | 18,538,418 | 2021 |
What was the outcome of reaction 'Accidental overdose'? | SEVERE ACUTE TOXIC EXPOSURES IN CHILDREN AND ADOLESCENTS: CASE SERIES.
OBJECTIVE
To describe a case series of severe acute toxic exposures (SATE) in individuals <20 years old followed-up by a regional Poison Control Center (PCC).
METHODS
Descriptive cross-sectional study. All patients who were <20yo and classified as... | Fatal | ReactionOutcome | CC BY | 32638947 | 18,538,418 | 2021 |
What was the outcome of reaction 'Bradycardia'? | SEVERE ACUTE TOXIC EXPOSURES IN CHILDREN AND ADOLESCENTS: CASE SERIES.
OBJECTIVE
To describe a case series of severe acute toxic exposures (SATE) in individuals <20 years old followed-up by a regional Poison Control Center (PCC).
METHODS
Descriptive cross-sectional study. All patients who were <20yo and classified as... | Fatal | ReactionOutcome | CC BY | 32638947 | 18,538,418 | 2021 |
What was the outcome of reaction 'Brain death'? | SEVERE ACUTE TOXIC EXPOSURES IN CHILDREN AND ADOLESCENTS: CASE SERIES.
OBJECTIVE
To describe a case series of severe acute toxic exposures (SATE) in individuals <20 years old followed-up by a regional Poison Control Center (PCC).
METHODS
Descriptive cross-sectional study. All patients who were <20yo and classified as... | Fatal | ReactionOutcome | CC BY | 32638947 | 18,538,418 | 2021 |
What was the outcome of reaction 'Death'? | SEVERE ACUTE TOXIC EXPOSURES IN CHILDREN AND ADOLESCENTS: CASE SERIES.
OBJECTIVE
To describe a case series of severe acute toxic exposures (SATE) in individuals <20 years old followed-up by a regional Poison Control Center (PCC).
METHODS
Descriptive cross-sectional study. All patients who were <20yo and classified as... | Fatal | ReactionOutcome | CC BY | 32638947 | 18,475,028 | 2021 |
What was the outcome of reaction 'Depressed level of consciousness'? | SEVERE ACUTE TOXIC EXPOSURES IN CHILDREN AND ADOLESCENTS: CASE SERIES.
OBJECTIVE
To describe a case series of severe acute toxic exposures (SATE) in individuals <20 years old followed-up by a regional Poison Control Center (PCC).
METHODS
Descriptive cross-sectional study. All patients who were <20yo and classified as... | Fatal | ReactionOutcome | CC BY | 32638947 | 18,538,418 | 2021 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.